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Reference equations for lung function screening of healthy
never-smoking adults aged 18-80 years
Abstract
The need for updated spirometric reference values to be used on European populations is widely
acknowledged, especially for subjects aged >70 yrs. Their reference values are generally based on
extrapolations. The aim of the present study was to calculate reference values for lung function
screening of healthy, never-smoking adults aged 18-80 yrs and to compare them with the most widely
used reference equations. Results of screening spirometry of 8,684 healthy, never-smoking adults were
used to calculate mean values and fifth percentiles of lung function variables. The European Community
of Coal and Steel (ECCS) reference equations underestimate forced expiratory volume in one second
(FEV(1)) and forced vital capacity (FVC). For example, in 50-yr-old males (height 175 cm), lower
limits of normal for FEV(1) are underestimated by 198 mL, and for FVC by 210 mL. In 50-yr-old
females (height 165 cm), lower limits of normal for FEV(1) are underestimated by 191 mL, and for
FVC by 270 mL. The decline of FVC in elderly subjects is steeper than predicted by the ECCS.
Reference equations derived from spirometry data locally collected in a practical setting by well-trained
personnel might be more appropriate for everyday use than generally used equations based on data from
scientific studies in the distant past.
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ABSTRACT: The need for updated spirometric reference values to be used on European
populations is widely acknowledged, especially for subjects aged .70 yrs. Their reference values
are generally based on extrapolations. The aim of the present study was to calculate reference
values for lung function screening of healthy, never-smoking adults aged 18–80 yrs and to
compare them with the most widely used reference equations.
Results of screening spirometry of 8,684 healthy, never-smoking adults were used to calculate
mean values and fifth percentiles of lung function variables.
The European Community of Coal and Steel (ECCS) reference equations underestimate forced
expiratory volume in one second (FEV1) and forced vital capacity (FVC). For example, in 50-yr-old
males (height 175 cm), lower limits of normal for FEV1 are underestimated by 198 mL, and for FVC
by 210 mL. In 50-yr-old females (height 165 cm), lower limits of normal for FEV1 are underestimated
by 191 mL, and for FVC by 270 mL. The decline of FVC in elderly subjects is steeper than predicted
by the ECCS.
Reference equations derived from spirometry data locally collected in a practical setting by
well-trained personnel might be more appropriate for everyday use than generally used equations
based on data from scientific studies in the distant past.
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T
he comparison of results of lung function
tests with normal values may influence
decisions that have important implications
both for individuals and for the healthcare
system. Several sets of normal values have been
published over the last decades and ‘‘normality’’
for a given age and height varies considerably
across these studies. Such variations may be
explained by the selection criteria of ‘‘normal’’
populations, cohort effects, measurement tech-
niques and devices, biological variability across
populations and statistical modelling [1–3]. Major
arguments for updating reference values on a
regular basis are birth cohort effects (e.g. changes
in the distribution of lung function at a given age
over time) and new technical equipment [4]. If no
updating is performed, normal values may
gradually lose their sensitivity in detecting
abnormal conditions at an early stage.
Standardisation procedures have been improved
and computer-based equipment allows ad hoc
decisions with regard to acceptability and repro-
ducibility of spirometric manoeuvres [5, 6].
The European Community of Coal and Steel
(ECCS) prediction equations, which are most
widely used in Europe, were derived from lung
function measurements of subjects, including
smokers, studied in the years 1954–1980, from
different study populations and from several
data sets. Thus their value for the interpretation
of spirometric tests has been challenged [7–9].
Current guidelines do not recommend a specific
set of equations for use in Europe. There is a
major need for new studies to derive updated
reference equations for lung function, especially
for elderly persons [10]. Recent recommendations
on equipment and standardisation of procedures
propose reference values based on cross-sectional
studies of lifetime nonsmokers [2, 5, 8]. It has
been shown that wheeze, breathlessness and
cough influence lung function parameters,
whereas chronic phlegm was not associated with
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airway obstruction or reduced forced expiratory volume in one
second (FEV1) in some surveys, suggesting that perhaps not all
respiratory symptoms need to be accounted for when defining a
healthy reference population used to derive reference values [3].
Most reference equations used in North America and Europe
have been derived from studies that included relatively small
numbers of individuals aged .65 yrs. Only a few sets of
equations have been published for elderly lifetime nonsmokers
of Caucasian-American origin [11–13]. Since international
guidelines discourage the use of spirometry reference equa-
tions for ages or heights outside the range covered by the data
that generated them, there is a need to collect lung function
data from elderly persons [2, 14].
In the present study, the results provided are based on a large
cross-sectional sample from a Central European population.
The present study is unique in that empirically based reference
equations of forced spirometry are presented for subjects aged
18–80 yrs. The reference equations used in the present study
for the means and the fifth percentiles as lower limits of
normal range account for changes in the distribution of lung
function with age and height. Reference values from the
present study are compared for the entire age range with those
from the Swiss Cohort Study on Air Pollution and Lung
Diseases in Adults (SAPALDIA), those from the ECCS and
those from the third National Health and Nutrition
Examination Survey (NHANES III) [7, 15–17]. Reference values
for elderly subjects are compared with other reference sets that
were derived for individuals aged .65 yrs [11, 13, 17–19].
METHODS
In the present cross-sectional study, lung function test results
collected by the ‘‘LuftiBus’’ team in the greater Zurich
metropolitan area (Zurich, Switzerland) between December
2000 and August 2005 were analysed. The LuftiBus project is
maintained by the Lung Association of Zurich. It consists of a
bus equipped with two flow-sensing spirometers that tours
mainly the greater Zurich area and offers spirometry measure-
ments to the general public. Spirometry data are recorded
electronically along with data from a standardised interviewer-
administered questionnaire collecting basic information on the
health and lifestyle of subjects. Lung function tests are charged
at 10 CHF to adults to cover the costs on a nonprofit basis.
Reference population
From a total of 20,460 subjects, 8,684 were included in the
sample used to derive normal values for spirometric param-
eters (table 1). Subjects were excluded if they met at least one
of the exclusion criteria (table 2). Never-smokers were defined
as subjects with a cumulative smoking history of ,1 pack-yr
(a pack-yr is defined as years of smoking 6 the number of
cigarettes smoked per day divided by 20). Due to the ongoing
migration in Europe and mixture of ethnical backgrounds, and
due to the very small proportion of non-Caucasian people in
Switzerland, no exclusion was made based on race or
nationality [20]. Thus, ethnicity was not assessed system-
atically for the whole study population. Ethnicity was recorded
in a subset of 3,061 consecutive subjects of the reference sample
(1,356 males and 1,705 females) measured in the years 2004 and
2005 and, thereof, non-Caucasian subjects accounted for 19
(1.1%) females and 17 (1.3%) males.
Spirometry
During the time of data collection, the LuftiBus was equipped
with two computerised pneumotachographs (SensorMedics1
Vmax Legacy 20c spirometer run by Vision 7-2b software;
VIASYS, Yorba Linda, CA, USA). The volume signal of the
equipment was calibrated at least once daily with a 3-L
syringe. Tests were performed in a sitting position according to
American Thoracic Society (ATS) guidelines without nose-clips
after an oral instruction by the technician [2, 14]. Participants
were assisted by eight specially trained lung function
technicians who performed immediate on-screen evaluation
of major acceptability criteria (including start, duration and
end of test) in addition to the automated review performed by
the computer software. As recommended by the ATS in 1994
[14], data that did not meet reproducibility criteria were not
excluded, but subjects were asked to perform up to a
maximum of eight manoeuvres in an attempt to obtain
reproducible results. From a minimum of two acceptable tests,
the largest forced vital capacity (FVC) and FEV1 were selected,
regardless of the manoeuvre. All other parameters were taken
from the trial with the largest sum of FVC and FEV1. Self-
reported values for height were used.
Statistical methods
The methodology used by the SAPALDIA team was repro-
duced. In a first step, prediction equations for the mean were
estimated. Equations for the fifth percentiles, which were the
TABLE 1 Inclusion characteristics for study population
Males Females Total
Subjects n 9738 10722 20460
Health criteria
satisfied
7371 (75.7) 7803 (72.8)
15174 (74.2)
Never-smokers 4565 (46.9) 7009 (65.4) 11574 (56.6)
All criteria satisfied 3512 (36.1) 5172 (48.2) 8684 (42.4)
Data are presented as n (%), unless otherwise stated.
TABLE 2 Exclusion criteria
Former or current smokers o1 pack-yrs
Current acute respiratory disease
Common cold
Acute bronchitis
Current respiratory symptoms
Cough
Wheezing
Shortness of breath with rest or exertion
Phlegm
History of asthma
Current treatment with asthma medication
History of chronic obstructive pulmonary disease or chronic bronchitis
History of other lung diseases
Lung operations
Pulmonary embolism
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primary focus of interest as lower limits of the normal range,
were then estimated from the residuals of the models for the
mean. All regression models were stratified by sex. The
methods have been described in detail previously [15, 16].
Prediction equations for the mean
To estimate equations for the mean, the natural logarithms of
lung function variables were regressed against ln(height), age
and quadratic function of age. The rationale for considering
lung function variables on the logarithmic scale was the
assumption that the dependency of average lung function (LF)
on height (H) and age (A) is suitably described by a function of
the form:
LF5Hc6f(A) (1)
Whereas estimating the exponent c from the untransformed
data requires the solution of a nonlinear regression problem,
the logarithmic transformation of the equation turns the
regression problem for c into a linear one. The piecewise
quadratic model was only retained if its fit was significantly
better than the one of a simple quadratic model defined over
the entire interval. If such a simplified model proved to be
sufficiently adequate, it was also tested whether or not the
quadratic age term was statistically significant.
Prediction equations for fifth percentiles
The next step was to compute fifth percentiles according to a
new method for estimating percentile curves using weighted
L1 regression. Thus, instead of minimising the sum of squared
residuals, a weighted sum of the absolute values of the
residuals was minimised. These residuals were again
regressed against age. If:
y5a + b6A (2)
denotes the estimated regression line for the fifth percentile of
r5ln(LFobserved/LFpredicted) (3)
as a function of age, then;
y5LFpredicted6exp(a + b6A) (4)
is an estimate of the fifth percentile of lung function for a given
age. To test whether a linear age term was sufficient to describe
the age dependency of the fifth percentile of r, an indicator
variable U was defined taking the value of 1 for residuals:
rfa + b6A (5)
and the value 0 for residuals:
r.a + b6A (6)
and a logistic regression model for U in terms of the covariates
A and A2 was computed. The quadratic term did not reach
statistical significance for any of the lung function parameters
considered, thus suggesting that the model with the linear age
term was sufficient throughout. In an analogous way, it could
be verified that the fifth percentile of r did not significantly
depend on the height of the individual.
Comparisons of reference equations
The newly derived reference equations were compared with
those most widely used in Europe (ECCS) and the USA
(NHANES III), as well as the most recent Swiss reference
values (SAPALDIA) [8, 15–17]. In addition, in order to
especially address the concerns that might arise due to the
possible over-reporting of height in elderly patients, reference
values of 65–80-yr-old subjects were compared with several
sets of reference equations that were recently published for this
population [11, 13, 17–19].
RESULTS
The main characteristics of the study population are shown in
table 3. Demographic data of the 8,684 subjects show an over-
representation of females satisfying the inclusion criteria
because females were more likely to have never smoked than
males and females were, to a lesser extent, over-represented in
the study sample.
The prediction equations for the mean of the lung function
variables are displayed in table 4 as:
LF5exp(a + b6ln(H) + c16A + c26A2) (7)
where LF represents any of the lung function variables
measured (FVC, FEV1, FEV1/FVC, maximal instantaneous
forced expiratory flow when 75% of the FVC remains to be
exhaled (MEF75), maximal instantaneous forced expiratory
flow when 50% of the FVC remains to be exhaled (MEF50), and
maximal instantaneous forced expiratory flow when 25% of
the FVC remains to be exhaled (MEF25)). This equation is
equivalent to:
ln(LF)5a + b6ln(H) + c16A + c26A2 (8)
The equations for the fifth percentiles, which are generally
recommended as a lower limit of the normal range, are
displayed in table 5. They are of the same form as those for the
mean. The ranges of application for these reference equations
are ages 18–80 yrs and heights of 140–200 and 130–190 cm in
males and females, respectively.
The choice of two age intervals (one for the ages 18–25 yrs and
one for the interval .25 yrs) was suggested by the ECCS, who
had modelled lung function by a piecewise linear function of
age. The SAPALDIA team had found that, even with a
TABLE 3 Height characteristics and age distribution of
reference sample
Males Females
Subjects n 3512 5172
Height# cm 176.3¡7.4 163.3¡6.8
Age# yrs 47.3 (18.2) 52.9 (17.5)
,30 742 (21.1) 625 (12.1)
30–39 525 (14.9) 649 (12.5)
40–49 659 (18.8) 821 (15.9)
50–59 592 (16.9) 936 (18.1)
60–69 504 (14.4) 1119 (21.6)
70–79 376 (10.7) 822 (15.9)
.79 114 (3.2) 200 (3.9)
Data are presented as mean¡SD or n (%), unless otherwise indicated. #: self-
reported values were used.
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quadratic function of age, a separate model for subjects aged
,25 yrs was warranted [8, 21]. However, in the present study,
separate equations did not fit the data significantly better than
a single equation. Results for each lung function variable refer
to participants who performed the tests according to ATS
quality criteria [14].
Comparisons with the reference equations provided by the
ECCS for 18–70-yr-old subjects and the recently published
Swiss values for subjects aged 18–60 yrs are shown in figure 1
for males and in figure 2 for females [15]. However, the present
sample included a considerable number of subjects aged
.70 yrs, so that the estimation of reference equations could be
extended to the age of 80 yrs.
In males as well as in females, the volumes predicted by
reference equations for the fifth percentile of FEV1 from the
present study are higher than those from the ECCS through-
out. In 50-yr-old males (height 175 cm), lower limits of normal
for FEV1 are underestimated by 198 mL, those of 50-yr-old
females (height 165 cm) by 191 mL by the ECCS reference
equations in comparison to the LuftiBus data. In 30-yr-old
males (height 175 cm) and females (height 165 cm), lung
volumes predicted by the present study’s reference values are
86 and 101 mL higher than those from the ECCS, respectively.
However, the difference practically vanishes at age 70 yrs,
indicating that the reference values for FEV1 provided by the
ECCS equations underestimate the decline of lung volumes in
elderly females.
For FVC, the present study’s reference equations for the fifth
percentile provide the lowest values in males aged 18–27 yrs.
Lower limits of normal for FVC are underestimated by the
ECCS reference equations in comparison with the LuftiBus
data by 210 mL in 50-yr-old males (height 175 cm) and by
270 mL in 50-yr-old females (height 165 cm). In 30-yr-old
males (height 175 cm) and females (height 165 cm), lung
volumes predicted by the present study’s reference values are
42 and 107 mL higher than those from the ECCS, respectively.
In both sexes, the decline of FVC with age is steeper than
predicted by the ECCS equations.
Reference equations provided by SAPALDIA give the highest
values for fifth percentiles of FEV1 and FVC throughout, with
the lower limits of NHANES III showing almost identical
values. By contrast, the present study’s values for the lower
limit of normal for MEF75 in all age groups of both sexes are
highest among the reference data compared. For MEF25, the
present study’s data indicate that the decline of late flows with
age is not as steep as suggested by the ECCS and SAPALDIA.
Figure 3 illustrates the decline of FVC with age for male
subjects aged 65–80 yrs compared with published reference
values for elderly subjects [11, 13, 17–19]. Regarding the
decline of lung volumes with age, the present data are in line
with other published reference values (i.e. corresponding
curves run almost parallel), indicating that over-reporting of
stated height in elderly subjects has not occurred to a
significant extent.
DISCUSSION
The present authors derived reference equations for screening
spirometry from data collected in a screening programme
(LuftiBus) among 8,684 healthy, never-smoking volunteers in
the period 2000–2005. Fifth percentiles as lower limits of normal
were derived according to a new statistical method [16].
TABLE 4 Prediction equations for the means of lung
function variables
Equation R2#
Males
FVC L exp(-10.258+2.280 ln(H)+0.00676A-0.000124A2) 0.549
FEV1 L exp(-8.957+2.014 ln(H)+0.00281A-0.000105A2) 0.639
MEF75 L?s-1 exp(-2.227+0.812 ln(H)+0.00977A-0.000132A2) 0.108
MEF50 L?s-1 exp(-3.055+0.911 ln(H)+0.00249A-0.000109A2) 0.226
MEF25 L?s-1 exp(-3.970+1.009 ln(H)-0.01645A-0.000020A2) 0.419
FEV1/FVC % exp(+6.291-0.341 ln(H)-0.00441A+0.000026A2) 0.126
PEF L?s-1 exp(-3.760+1.170 ln(H)+0.00706A-0.000110A2) 0.233
Females
FVC L exp(-9.069+2.013 ln(H)+0.00847 A-0.000155A2) 0.562
FEV1 L exp(-8.397+1.865 ln(H)+0.00570 A-0.000150A2) 0.526
MEF75 L?s-1 exp(-2.716+0.867 ln(H)+0.00963 A-0.000140A2) 0.184
MEF50 L?s-1 exp(-2.131+0.674 ln(H)+0.00895 A-0.000180A2) 0.253
MEF25 L?s-1 exp(-4.861+1.145 ln(H)-0.01120 A-0.000096A2) 0.423
FEV1/FVC % exp(+5.637-0.219 ln(H)-0.00249 A+0.000004A2) 0.039
PEF L?s-1 exp(-4.794+1.316 ln(H)+0.00926 A-0.000143A2) 0.329
FVC: forced vital capacity; FEV1: forced expiratory volume in one second;
MEF25 or 50 or 75: maximal instantaneous forced expiratory flow when 25, 50 or
75% of the FVC remains to be exhaled, respectively; PEF: peak expiratory flow;
H: height (cm); A: age (yrs); exp(x): ex. #: fraction of explained variance.
TABLE 5 Prediction equations for the fifth percentiles of
lung function variables
Equation
Males
FVC L exp(-10.437+2.280 ln(H)+0.00532A-0.000124A2)
FEV1 L exp(-9.111+2.014 ln(H)+0.00102A-0.000105A2)
MEF75 L?s-1 exp(-2.524+0.812 ln(H)+0.00661A-0.000132A2)
MEF50 L?s-1 exp(-3.338+0.911 ln(H)-0.00289A-0.000109A2)
MEF25 L?s-1 exp(-4.262+1.009 ln(H)-0.02485A-0.000020A2)
FEV1/FVC % exp(+6.180-0.341 ln(H)-0.00529A+0.000026A2)
PEF L?s-1 exp(-3.992+1.170 ln(H)+0.00493A-0.000110A2)
Females
FVC L exp(-9.213+2.013 ln(H)+0.00616A-0.000155A2)
FEV1 L exp(-8.521+1.865 ln(H)+0.00357A-0.000150A2)
MEF75 L?s-1 exp(-2.977+0.867 ln(H)+0.00698A-0.000140A2)
MEF50 L?s-1 exp(-2.374+0.674 ln(H)+0.00330A-0.000180A2)
MEF25 L?s-1 exp(-5.140+1.145 ln(H)-0.02002A-0.000096A2)
FEV1/FVC % exp(+5.524-0.219 ln(H)-0.00313A+0.000004A2)
PEF L?s-1 exp(-5.032+1.316 ln(H)+0.00767A-0.000143A2)
FVC: forced vital capacity; FEV1: forced expiratory volume in one second;
MEF25 or 50 or 75: maximal instantaneous forced expiratory flow when 25, 50 or
75% of the FVC remains to be exhaled, respectively; PEF: peak expiratory flow;
H: height (cm); A: age (yrs); exp(x): ex. #: fraction of explained variance.
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For FVC and FEV1, the present study’s reference equations for
the lower limit of normal provide values that are lower than
the ones from SAPALDIA and NHANES III but higher than
the ones from the ECCS in the age range 30–70 yrs. The present
study’s reference equations provide the lowest values in males
aged 18–27 yrs for FVC only.
For both sexes, the decline of FVC in elderly subjects appears
to be underestimated by the equations from the ECCS. The
present study’s reference values also predict a steeper decline
of FEV1 in elderly females. By contrast, the present study’s
curves for the decline of MEF25 with age are not as steep as the
ones from the ECCS and SAPALDIA.
The present study’s equations differ from those derived by the
ECCS with regard to their mathematical form and to the nature
of the underlying data. The ECCS reference equations were
obtained by summarising published regression equations from
older surveys published between the 1950s and 1980s that
employed different instruments [8].
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FIGURE 1. Age dependency of mean values and fifth percentiles of a) forced expiratory volume in one second (FEV1), b) forced vital capacity (FVC), c) FEV1/FVC,
d) maximal instantaneous forced expiratory flow when 75% of the FVC remains to be exhaled (MEF75), e) MEF when 50% of the FVC remains to be exhaled (MEF50), and f)
MEF when 25% of the FVC remains to be exhaled (MEF25) in males (height 175 cm) in comparison with published reference values. ——: European Community of Coal and
Steel; ------: Swiss Cohort Study on Air Pollution and Lung Diseases in Adults; ?????????: third National Health and Nutrition Examination Survey; – – – –: LuftiBus.
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There are several differences in the methods applied in the
SAPALDIA and the LuftiBus studies, both of which evaluated
samples of the Swiss population. Subjects participating in the
LuftiBus project were volunteers who were charged for the test
on a nonprofit basis. In SAPALDIA, participants were
randomly selected among the inhabitants of the study sites.
This might result in some selection bias in the present study,
despite the large population sample with a proper distribution
of body height.
It has been demonstrated that using different spirometers may
account for systematic deviations of lung function parameters
of .5%. The systematic differences may be due to both
hardware and software [22]. Thus, the systematically higher
lung volumes derived by SAPALDIA could be originating
from a systematic bias due to different equipment.
As proposed by the ATS, lung function tests that did not meet
reproducibility criteria were not excluded from the present
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FIGURE 2. Age dependency of mean values and fifth percentiles of a) forced expiratory volume in one second (FEV1), b) forced vital capacity (FVC), c) FEV1/FVC,
d) maximal instantaneous forced expiratory flow when 75% of the FVC remains to be exhaled (MEF75), e) MEF when 50% of the FVC remains to be exhaled (MEF50), and f)
MEF when 25% of the FVC remains to be exhaled (MEF25) in females (height 165 cm) in comparison with published reference values. ——: European Community of Coal and
Steel; ------: Swiss Cohort Study on Air Pollution and Lung Diseases in Adults; ?????????: third National Health and Nutrition Examination Survey; – – – –: LuftiBus.
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investigation [14]. In contrast, in SAPALDIA, only reproduci-
ble lung function tests results were evaluated. This probably
results in systematically higher lung volumes.
Another issue could be the origin of the study population.
Subjects from the present study population originate from the
greater Zurich metropolitan area, whereas SAPALDIA
included subjects from rural as well as from urban Swiss
areas. Local exposure to traffic has been demonstrated to have
adverse effects on children’s lung development, which could
result in lung function deficits persisting into later life [23].
This might even have resulted in differences between the lung
function tests of the two different birth cohorts of the
SAPALDIA and the LuftiBus project. There is evidence that
pollution from fossil fuel combustion is associated with
decrements in lung function, which might, in part, explain
the lower values in the present study having been derived
from subjects predominantly living in urban areas [24].
The present study has several limitations as data include
asymptomatic never-smokers without known pulmonary
disease. Moreover, no clinical or chest radiographical exam-
inations were performed, which might result in the inclusion
of some patients with unknown asymptomatic lung disease.
There are limited possibilities to quantify factors that may
influence lung function, such as occupational exposure,
passive smoking and the effect of chest injuries or chest
surgical interventions. The nature of the evaluation did not
account for all these parameters in detail. Additionally, access
to medical data was not possible, except for those provided by
the study subjects themselves. The current authors believe that
the exclusion of subjects suffering from respiratory symptoms,
such as dyspnoea (with or without exercise) or cough might
have resulted in the exclusion of a large proportion of those
patients. However, in this regard, the present study is in line
with most other studies having published reference equations
for lung function. Smoking status was quantified as ‘‘cumu-
lative numbers of pack-yrs’’ and never-smokers were defined
as subjects with a cumulative smoking history of ,1 pack-yr.
As it has been shown that a cumulative smoking history of
f5 pack-yrs barely influences lung volumes and, due to a lack
of evidence for other thresholds in the current literature, not
excluding occasional cigarette smokers, pipe smokers or
nontobacco smokers with a cumulative history of ,1 pack-yr
might be acceptable for deriving reference equations [25].
Regardless of the fact that deriving reference equations from
large groups of volunteers is thought to be acceptable,
provided that criteria for normal selection and proper
distribution of anthropometric characteristics are satisfied,
some selection bias might have crept in [10]. In particular, the
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FIGURE 3. Age dependency of mean values and fifth percentiles of a) forced expiratory volume in one second (FEV1) and b) forced vital capacity (FVC) in males (height
175 cm) and of c) FEV1 and d) FVC in females (height 165 cm, 55 kg) aged 65–80 yrs in comparison with published reference values. &: GARCIA-RIO et al. [11]; h:
LANGHAMMER et al. [18]; $: LuftiBus; #: FALASCHETTI et al. [19]; ¤: MCDONNELL et al. [13]; e: third National Health and Nutrition Examination Survey.
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charge for the test might have kept certain groups of
individuals from participating.
Using self-reported height, or estimating height from arm span
is regarded as an option in the clinical setting when spirometry
is performed in patients who have conditions that hamper the
standing position [10]. Self-reported height was shown to give
an accurate representation of true values in different popula-
tions, but age has been stated to be an important factor for
misreporting height [26–30]. Height overestimation in the
elderly is congruent with age-related corporal changes. The
present data concerning the decline of FVC with age, however,
are consistent with those from other publications that used
measured height to derive reference equations for subjects
aged 65–85 yrs [11, 13, 17–19].
Body mass index (BMI) has been shown to have significant
effects on all the lung volumes, especially the functional
residual capacity and expiratory reserve volume [31]. As a rule
of thumb, lung volumes decrease as body weight increases.
Thus, attempts have been made to introduce BMI as an
independent variable in newly derived reference equations
[32]. In a subset of the present study’s subjects, the current
authors assessed whether BMI could be included as a predictor
of lung function. Thereby, BMI was shown not to influence
lung volumes. Moreover, in analogy to height, self-reported
weight was recorded in the present study. Due to a tendency of
study participants to over-report height and, to a greater
extent, underreport weight, stated BMI was demonstrated to
be systematically underestimated in various studies [28, 33].
Thus, the current authors believe that using self-reported BMI
is of limited value for deriving reference equations.
As stated in the 1994 update of the ATS guidelines for
standardisation of spirometry [14], nose-clips do not appreci-
ably influence the FVC when using the open-circuit technique.
However, their use was encouraged, especially when perform-
ing a slow vital capacity manoeuvre, because some people
breathe through the nose. The use of nose-clips was considered
mandatory if a closed-circuit technique with carbon dioxide
absorption was used. Guidelines from 2005 [34], published at
the end of data collection for the LuftiBus study, recommend
the use of a nose-clip or manual occlusion of the nares. It has
been demonstrated that the application of a nose-clip has no
significant impact on measurement of peak expiratory flow,
but its importance for the other lung function parameters, to
the present authors’ knowledge, has not been studied [35].
That the present study’s lung function tests were performed
without a nose-clip might, nevertheless, partly explain the
observed differences with the SAPALDIA reference equations,
since a certain loss of air through the nasal route is likely to
have occurred at least in some subjects.
It was proposed that reference equations should be derived
from a population most similar to that for which the equations
are to be used and based on measurements obtained by the
same instruments and testing procedures [32]. Since the
methodology used in the LuftiBus project mirrors the methods
used in daily practice, where measurement of height and
application of a nose-clip is often abandoned, the present
results may thus provide a valuable contribution to lung
function testing within a routine outpatient setting. The
present study in particular meets the major need for updated
and empirically derived reference equations of forced spiro-
metry for subjects aged 65–80 yrs.
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